When the tests disagree: glaucoma suspect with unreliable fields and a myopic OCT
Mr H, 61, is a retired teacher with a mother who had glaucoma. He attends for a glaucoma assessment because his optometrist noted 'suspicious discs'. He is a high myope (-5.50 DS both eyes) and has no visual symptoms. IOP by Goldmann is 22 mmHg right and 23 mmHg left at 10:00, CCT 540 microns both. Optic discs show vertical cup-to-disc ratios of 0.60 right and 0.65 left with some inferior rim thinning, but no haemorrhage. 24-2 visual fields show scattered defects; fixation losses are 4/6, false positives 25%, false negatives 10%. OCT retinal nerve fibre layer shows a red inferior sector in the left eye but signal strength is 6/10 and there is marked peripapillary atrophy. Gonioscopy is open. He asks whether he has glaucoma and whether he needs drops.
1. How do you interpret the tests and what is your working diagnosis?
Read the worked answer
The working diagnosis is glaucoma suspect, not definite glaucoma. The tests are discordant and several are unreliable.
- Visual fields: fixation losses of 4/6 and false positives of 25% exceed acceptable reliability limits. The scattered defects cannot be used to confirm glaucomatous loss. The field needs repeating with better technique.
- OCT: a red inferior sector is not diagnostic in a high myope with poor signal strength and marked peripapillary atrophy. Myopic tilt and peripapillary atrophy can cause segmentation error and false thinning. Signal strength of 6/10 is borderline and should be repeated.
- Optic discs: cup-to-disc ratios of 0.60 and 0.65 with inferior rim thinning are suspicious, especially with a family history, but are not specific. Disc size, rim width and any haemorrhage or notching matter.
- IOP and CCT: 22-23 mmHg is borderline, and a CCT of 540 microns is average. IOP alone does not diagnose glaucoma.
- Gonioscopy: open angles make angle-closure less likely but do not exclude open-angle glaucoma. The key judgement is to avoid starting lifelong drops on unreliable data while not dismissing a real risk.
2. What repeat testing, referral or monitoring plan would you arrange?
Read the worked answer
I would arrange a structured repeat assessment rather than acting on a single inconsistent dataset.
- Repeat visual fields: at least two reliable 24-2 tests, with coaching on fixation and false positives, preferably on the same machine. Look for repeatable defects that respect the horizontal midline and match the disc.
- Repeat OCT: ensure good signal strength, check segmentation and compare with the optic disc photo. Interpret with caution because of high myopia and peripapillary atrophy.
- Optic disc imaging: stereoscopic disc photos or careful clinical drawing for baseline. Document rim thinning, notching, haemorrhage and vessel changes.
- IOP: repeat at different times of day and consider a diurnal curve.
- Pachymetry and gonioscopy: already done; repeat gonioscopy if there is any doubt.
- Referral: I would refer to ophthalmology if there is a repeatable field defect, progressive rim thinning, a disc haemorrhage, IOP rising into the high twenties, or if I cannot obtain reliable baseline testing. Given the family history and suspicious discs, a baseline ophthalmology opinion is reasonable even if the repeat tests are stable.
- Monitoring: if the risk is judged low after repeat testing, monitor with reliable fields, disc imaging and IOP every 6-12 months rather than starting treatment.
3. How would you explain the uncertainty and the plan to Mr H?
Read the worked answer
I would be honest but not alarming. I would say that his discs look suspicious and his family history matters, but the tests do not yet give a clear answer. The field test was unreliable because of fixation and false-positive responses, and the OCT scan is harder to interpret in a highly myopic eye with peripapillary atrophy. That does not mean the tests are useless; it means we need better-quality repeats before deciding about drops.
I would explain:
- glaucoma is a chronic optic nerve disease, and treatment is aimed at reducing risk of progression, not curing it;
- drops are generally lifelong and have side effects and cost, so we should not start them on uncertain evidence;
- the plan is repeat fields, repeat OCT and disc assessment, and review of the risks;
- if the repeat tests show definite damage or progression, referral and treatment will be recommended;
- if the tests remain stable and reliable, monitoring is appropriate;
- he should return sooner if he notices vision changes, and he should continue regular reviews.
I would check his understanding and give written information. The goal is a shared decision, not a false choice between 'you have glaucoma' and 'you are fine'.